All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Reported results | 2006-006550-96 | ORAL INSULIN FOR PREVENTION OF DIABETES IN RELATIVES AT RISK FOR TYPE 1 DIABETES MELLITUS | 2017-11-01 | due-trials |
Listed as ongoing, but also has a completion date and reported results | 2013-002248-98 | Anti-CD3 MAB (Teplizumab) for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus ANTI-CD3 MAB (TEPLIZUMAB) per la prevenzione del diabete in PARENTI a rischio di sviluppare di... | 2019-12-16 | bad-data |
Listed as ongoing, but also has a completion date and reported results | 2013-002249-13 | CTLA-4Ig (Abatacept) for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus | 2022-12-14 | bad-data |
Listed as ongoing, but also has a completion date and reported results | 2018-000659-42 | HYDROXYCHLOROQUINE FOR PREVENTION OF ABNORMAL GLUCOSE TOLERANCE AND DIABETES IN INDIVIDUALS AT-RISK FOR TYPE 1 DIABETES MELLITUS | 2022-07-11 | bad-data |